Sun Pharma sets 5 Feb 2026 record date for FY26 interim dividend
SUNPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.1 pts less than Nifty 100 and 0.7 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Sun Pharma informed the exchange that its Board will meet on 31 January 2026 to consider and approve unaudited standalone and consolidated financial results for Q3 and nine months ended 31 December 2025, and to consider approving the declaration of an interim dividend for FY 2025-26. If declared, the dividend will be paid to equity shareholders on the register as of Thursday, 5 February 2026. TDS will apply. Trading window is closed from 1 January to 2 February 2026.
Investors holding shares by the 5 Feb record date may receive an interim dividend; quantum not yet announced.